糖尿病患者持续口服治疗需求的评估。
Assessment of the need for continued oral therapy in diabetics.
作者信息
Tomkins A M, Bloom A
出版信息
Br Med J. 1972 Mar 11;1(5801):649-51. doi: 10.1136/bmj.1.5801.649.
Abstract
Hypoglycaemic agents were replaced by placebos in diabetic patients attending a hospital clinic. Of 62 patients observed, 43 (69%) relapsed within six months but blood sugar control remained unchanged in 19 (31%) during the period of observation.
摘要
在一家医院门诊就诊的糖尿病患者中，降血糖药物被安慰剂取代。在观察的62名患者中，43名（69%）在六个月内复发，但在观察期间，19名（31%）患者的血糖控制保持不变。
相似文献
1
Assessment of the need for continued oral therapy in diabetics.糖尿病患者持续口服治疗需求的评估。
Br Med J. 1972 Mar 11;1(5801):649-51. doi: 10.1136/bmj.1.5801.649.
2
A study of comparative effectiveness of oral hypoglycaemic agents in single dose in diabetes mellitus.
J Indian Med Assoc. 1971 Jun 16;56(12):366-70.
3
Editorial: Oral therapy in diabetes mellitus.
South Med J. 1974 Jun;67(6):635-8.
4
Oral therapy in diabetes.糖尿病的口服治疗
J R Coll Physicians Lond. 1972 Oct;7(1):61-8.
5
Long term observations with oral hypoglycemic drugs: sulphonylureas, biguanides and their combination.
Indian J Med Sci. 1970 Jul;24(7):393-403.
6
Effect of diet, sulphonylureas, and phenformin on peripheral glucose uptake in diabetes and obesity.饮食、磺脲类药物和苯乙双胍对糖尿病及肥胖症患者外周葡萄糖摄取的影响。
Lancet. 1968 Oct 12;2(7572):785-8. doi: 10.1016/s0140-6736(68)92452-5.
7
An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
Diabetologia. 1973 Sep:364-6. doi: 10.1007/BF01218448.
8
Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
Geriatrics. 1968 Sep;23(9):137-46.
9
Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).
S Afr Med J. 1969 Aug 9;43(32):1002-4.
10
Oral substitutes for insulin: modern appraisal of their action and indications.
Isr J Med Sci. 1972 Jun;8(6):677-710.
引用本文的文献
1
Wide variation in serum chlorpropamide concentration in outpatients.门诊患者血清氯磺丙脲浓度差异很大。
Eur J Clin Pharmacol. 1980 Aug;18(2):165-9. doi: 10.1007/BF00561585.
2
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.磺酰脲类降糖药的临床药理学：第2部分。
Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003.
3
Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.氯磺丙脲、格列本脲及安慰剂对仅靠饮食控制不佳的糖尿病患者的激素及代谢影响的交叉研究
Diabetologia. 1981;20(1):22-30. doi: 10.1007/BF00253812.
4
Oral hypoglycaemic agents. An update.口服降糖药。最新进展。
Drugs. 1984 Jul;28(1):62-78. doi: 10.2165/00003495-198428010-00004.
5
Oral therapy in diabetes.糖尿病的口服治疗
J R Coll Physicians Lond. 1972 Oct;7(1):61-8.
6
Trial of placebo in long-term chlorpropamide-treated diabetics.长期接受氯磺丙脲治疗的糖尿病患者使用安慰剂的试验。
Diabetologia. 1974 Jun;10(3):197-200. doi: 10.1007/BF00423034.
7
A selected public health bibliography with annotations.一份带有注释的公共卫生文献选集。
Am J Public Health. 1972 Jun;62(6):883-6. doi: 10.2105/ajph.62.6.883.
8
An audit of the care of diabetics in a group practice.一项关于联合诊所中糖尿病患者护理情况的审计。
J R Coll Gen Pract. 1976 Oct;26(171):734-42.
本文引用的文献
1
Tolbutamide in diabetes; some clinical and biochemical studies.甲苯磺丁脲治疗糖尿病；一些临床与生化研究
Br Med J. 1957 Aug 10;2(5040):327-31. doi: 10.1136/bmj.2.5040.327.
2
Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?
Diabetologia. 1971 Aug;7(4):237-9. doi: 10.1007/BF01211874.
3
Blood-sugar and arterial disease.血糖与动脉疾病。
Lancet. 1965 Sep 11;2(7411):505-8. doi: 10.1016/s0140-6736(65)91470-4.
Zotero 插件